BioNeutra International, Ltd.
BIMO · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $33 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $7 | $7 |
| Gross Profit | $0 | $0 | $26 | -$7 |
| % Margin | – | – | 79.3% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $54 | $55 | $85 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $54 | $55 | $85 | $2 |
| Operating Income | -$54 | -$55 | -$59 | -$8 |
| % Margin | – | – | -177.4% | – |
| Other Income/Exp. Net | -$14 | $0 | $0 | -$0 |
| Pre-Tax Income | -$68 | -$55 | -$59 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$68 | -$55 | -$59 | -$8 |
| % Margin | – | – | -177.4% | – |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | -33.3% | 25% | -300% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 163,430 | 163,430 | 163,430 | 163,430 |
| Weighted Avg Shares Out Dil | 163,430 | 163,430 | 163,430 | 163,430 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $14 | $0 | $0 | $0 |
| Depreciation & Amortization | $228 | $237 | $7 | $7 |
| EBITDA | -$54 | -$55 | -$52 | -$2 |
| % Margin | – | – | -156.8% | – |